Patent delisted for Taiho Oncology drug LONSURF

Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are five patents…

The post Patent delisted for Taiho Oncology drug LONSURF appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!